Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION)

This study is evaluating whether minimally invasive surgery using an endoscopic stapler device is safe and effective for early-stage cervical cancer. It compares outcomes to open surgery, examining whether this newer approach achieves similar cancer control with fewer complications. **You may be eligible if:** - You are a woman aged 20 or older - You have confirmed early-stage cervical cancer (FIGO stage IB1) — a tumor larger than 5mm deep or 7mm wide but not larger than 4 cm - Your cancer is squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma - You are scheduled for a specific type of radical hysterectomy (Querleu-Morrow type B or C) - Your blood counts, kidney function, and liver function are within acceptable ranges - You are in good general health (ECOG performance status 0 or 1) **You may NOT be eligible if:** - Your cancer is more advanced than stage IB1 - You have cancer involving other organs simultaneously - Your blood or organ function tests are outside acceptable ranges Talk to your doctor to see if this trial is right for you.